IGC Pharma, Inc.
IGC · AMEX
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$7,121 | -$13,000 | -$11,506 | -$15,016 |
| Dep. & Amort. | $618 | $637 | $657 | $651 |
| Deferred Tax | $0 | $0 | -$451 | $0 |
| Stock-Based Comp. | $1,640 | $1,773 | $2,843 | $2,197 |
| Change in WC | -$72 | $1,894 | $794 | $2,536 |
| Other Non-Cash | $140 | $3,497 | $616 | $2,170 |
| Operating Cash Flow | -$4,795 | -$5,199 | -$7,047 | -$7,462 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$112 | -$138 | -$619 | -$236 |
| Net Acquisitions | $0 | $0 | $538 | $0 |
| Inv. Purchases | $0 | $0 | -$154 | $0 |
| Inv. Sales/Matur. | $0 | $0 | -$538 | $0 |
| Other Inv. Act. | -$330 | -$179 | $538 | -$506 |
| Investing Cash Flow | -$442 | -$317 | -$235 | -$742 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$3 | -$3 | -$3 | -$3 |
| Stock Issued | $4,454 | $3,527 | $103 | $4,145 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $0 | $0 |
| Financing Cash Flow | $4,451 | $3,524 | $100 | $4,142 |
| Forex Effect | -$7 | -$6 | -$82 | -$26 |
| Net Chg. in Cash | -$793 | -$1,998 | -$7,264 | -$4,088 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $1,198 | $3,196 | $10,460 | $14,548 |
| End Cash | $405 | $1,198 | $3,196 | $10,460 |
| Free Cash Flow | -$5,277 | -$5,714 | -$7,666 | -$8,233 |